Your portfolio company's US GTM strategy
is built on assumption.
The default playbook has not changed in twenty years. Hire US country manager or CRO. Fund marketing. Launch outbound. Hope for traction. The typical failed US expansion costs $1-2M and 12-18 months before an operating partner has clean enough signal to redirect.
"The problem is not the product or the founder. The problem is sequencing."
The governed alternative
Validate the US market before you build for it. A governed entry path.
The US GTM Engine runs a structured, time-bounded validation gate before scaled US capital is deployed. A five-person fractional team operates as one engagement, with one scope and one point of accountability. The portfolio company gets a working US go-to-market. You get evidence before you commit the next tranche.
90 days. A validation gate
before scaled capital.
Your first US CRO will cost the portfolio company at least $400K in year one, with a 1-in-3 chance of leaving in 12 months. The promise usually is "I can activate my network of B2B buyers" — but a network promise is not a validated ICP or messaging framework, and relationships are not a repeatable pipeline.
The US Launch Sprint is a 90-day, fixed-cost engagement designed to produce validation before large financial commitments.
At day 90, the operating partner has CRM-documented evidence of US engagement quality, observable conversion patterns against a validated ICP, and a defensible answer to the question every investment committee asks: is the US opportunity real for this company, and at what scale?
We are built to finish, not to embed. The goal is a portfolio company running its own US go-to-market with confidence — on a timeline the operating partner can underwrite.